Cancer statistics, 2019
- PMID: 30620402
- DOI: 10.3322/caac.21551
Cancer statistics, 2019
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the National Center for Health Statistics. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2006-2015) was stable in women and declined by approximately 2% per year in men, whereas the cancer death rate (2007-2016) declined annually by 1.4% and 1.8%, respectively. The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with the most notable gaps for the most preventable cancers. For example, compared with the most affluent counties, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016. Some states are home to both the wealthiest and the poorest counties, suggesting the opportunity for more equitable dissemination of effective cancer prevention, early detection, and treatment strategies. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.
Keywords: cancer cases; cancer statistics; death rates; incidence; mortality.
© 2019 American Cancer Society.
Comment in
-
Think globally about cancer.Nat Med. 2019 Mar;25(3):351. doi: 10.1038/s41591-019-0402-x. Nat Med. 2019. PMID: 30842673 No abstract available.
Similar articles
-
Cancer statistics, 2018.CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4. CA Cancer J Clin. 2018. PMID: 29313949
-
Cancer Statistics, 2017.CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5. CA Cancer J Clin. 2017. PMID: 28055103
-
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17. CA Cancer J Clin. 2011. PMID: 21685461
-
Cancer disparities by race/ethnicity and socioeconomic status.CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93. doi: 10.3322/canjclin.54.2.78. CA Cancer J Clin. 2004. PMID: 15061598 Review.
-
Cancer statistics, 2004.CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. doi: 10.3322/canjclin.54.1.8. CA Cancer J Clin. 2004. PMID: 14974761 Review.
Cited by
-
The biological roles of CD47 in ovarian cancer progression.Cancer Immunol Immunother. 2024 Jun 4;73(8):145. doi: 10.1007/s00262-024-03708-3. Cancer Immunol Immunother. 2024. PMID: 38832992 Free PMC article. Review.
-
A prognostic binary classifier comprised of five critical mRNAs stratified pancreatic cancer patients following resection.Heliyon. 2024 May 17;10(11):e31302. doi: 10.1016/j.heliyon.2024.e31302. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38828350 Free PMC article.
-
Efficacy and safety of different cycles of neoadjuvant immunotherapy in resectable non-small cell lung cancer: A systematic review and meta-analysis.Heliyon. 2024 May 22;10(11):e31549. doi: 10.1016/j.heliyon.2024.e31549. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38828349 Free PMC article.
-
Enhancing chemosensitivity of PANC1 pancreatic cancer cells to gemcitabine using ANGTPL4, Notch1 and NF-κβ1 siRNAs.Future Sci OA. 2024 May 20;10(1):FSO918. doi: 10.2144/fsoa-2023-0145. eCollection 2024. Future Sci OA. 2024. PMID: 38817387 Free PMC article.
-
Immunological Roles of CCL18 in Pan‑Cancer and Its Potential Value in Endometrial Cancer.Mol Biotechnol. 2024 May 30. doi: 10.1007/s12033-024-01205-7. Online ahead of print. Mol Biotechnol. 2024. PMID: 38816548
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous